-
The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling sales.
-
Additionally, AstraZeneca plans to revoke marketing authorizations for its vaccine, Vaxzevria, within Europe due to reduced demand
-
Several studies have suggested that following COVID-19 vaccination, antibody levels may be lower in people with obesity than in the general population.
-
Florida's surgeon general, who cautioned young men against getting the COVID-19 vaccine, omitted information that showed catching the virus could increase the risk of a cardiac-related death much more than getting the mRNA shot.
-
In the 60-minute documentary titled ‘The Vial – India’s Vaccine Story’, PM Modi said the need of the hour was to develop a vaccine and for that, decision-making “could not move at the speed of files”
-
Talking about the tough decision of imposing a nationwide lockdown to curb the spread of the virus, PM Modi, in History TV18's documentary ‘The Vial – India’s Vaccine Story’, said he was able to educate people that ‘Jaan hai toh jahaan hai’
-
History TV18’s 60-minute documentary, titled The Vial – India’s Vaccine Story, is the first to feature PM Narendra Modi where he speaks in detail about India’s victory over the Covid-19 pandemic
-
Marrying technology with a spirit to eliminate the virus from the country also led to ingenious solutions such as the use of drones to deliver vaccines
-
‘The Vial – India’s Vaccine Story’ revealed how residents of Malana, a village in Parvati Valley, claim they are the descendants of Alexander the Great and view outsiders --- including health workers --- with suspicion
-
Narrated by actor Manoj Bajpayee, the 60-minute documentary that aired at 8pm on Friday traces India’s journey from deciding to develop a vaccine on its own to becoming the world’s saviour by providing the jabs to several countries
-
The government said the ICMR had simply provided a list of advantages and disadvantages of COVID-19 vaccines through reputed websites of WHO, CDC and the ministry where compiled global evidence on various vaccines is available.
-
In 2022, the Supreme Court delivered judgments that had wide-ranging ramifications. The apex court also revived the institution of the constitution bench during Chief Justice of India UU Lalit's 74-day tenure. As many as six constitution benches were formed to hear 25 cases, which will impact the law of the land. In this year-end special, Moneycontrol lists the SC's five most important judgments of 2022
-
China is a very different economy and its vaccination coverage is lower while infection rate is higher than India's, says Balasubramanian
-
The COVID-19 vaccine will now be offered to the adults earlier fully vaccinated with Covaxin or Covishield after the government incorporated changes in the CoWin app.
-
Business and Political News Highlights: CBI has arrested former MD & CEO of ICICI bank Chanda Kochhar & Chanda Kochhar in the alleged ICICI bank - Videocon loan fraud case
-
Antibodies in the nasal fluid, known as immunoglobulin A, or IgA, provide first-line defense against COVID-19 by blocking SARS-CoV-2 virus when it first enters the respiratory tract
-
Currently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V and Biological E Ltd's Corbevax are listed in the CoWin portal.
-
More than 375 million doses of the original vaccine, which Pfizer developed with the German drugmaker BioNTech, have been distributed in the U.S., according to the Centers for Disease Control and Prevention.
-
According to the Ministry of Health and Family Welfare, 219.32 crore doses of the coronavirus vaccine have been administered to beneficiaries across the country so far.
-
The managing director of vaccine manufacturing company says regulatory framework along with financing and market predictability are important bottlenecks in developing variant specific vaccines against evolving coronavirus
-
The vaccine has been approved by China. It is meant to be used as a booster dose.
-
As per recent studies, the BCG vaccine -- originally for tuberculosis (TB), can provide protection against COVID-19, and several infections such as leprosy and malaria.
-
The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by U.S. drug company Moderna conditional approval as a booster for adults on Monday.
-
Over 3.97 crore children in the age group of 12-14 years have been administered the first dose, while more than 6.14 crore adolescents in the age group 15-18 years have been given the first dose.
-
The recipients of Covaxin and Covishield, however, will also have an option of receiving the same vaccine they had taken for their primary vaccination
